Loring Wolcott & Coolidge Fiduciary Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64.2M Sell
252,775
-3,486
-1% -$812K 0.62% 40
2026
Q1
$61.1M Sell
256,261
-5,942
-2% -$1.38M 0.61% 39
2025
Q4
$58.8M Sell
262,203
-4,002
-2% -$791K 0.53% 43
2025
Q3
$51.2M Sell
266,205
-3,529
-1% -$605K 0.45% 45
2025
Q2
$41.2M Sell
269,734
-2,738
-1% -$421K 0.36% 47
2025
Q1
$42.3M Sell
272,472
-8,659
-3% -$1.35M 0.41% 46
2024
Q4
$43M Sell
281,131
-8,564
-3% -$1.33M 0.37% 47
2024
Q3
$47.4M Sell
289,695
-8,393
-3% -$1.34M 0.42% 46
2024
Q2
$45M Sell
298,088
-9,202
-3% -$1.37M 0.41% 50
2024
Q1
$45.8M Sell
307,290
-21,632
-7% -$3.44M 0.46% 48
2023
Q4
$52.3M Sell
328,922
-12,549
-4% -$1.92M 0.52% 43
2023
Q3
$51.3M Sell
341,471
-25,335
-7% -$4.18M 0.57% 39
2023
Q2
$60.7M Buy
366,806
+532
+0.1% +$85.9K 0.65% 38
2023
Q1
$56.8M Buy
366,274
+5,633
+2% +$910K 0.65% 35
2022
Q4
$63.7M Sell
360,641
-825
-0.2% -$142K 0.79% 34
2022
Q3
$59M Sell
361,466
-304
-0.1% -$51.4K 0.77% 33
2022
Q2
$64.2M Buy
361,770
+64
+0% +$11.4K 0.79% 35
2022
Q1
$64.1M Sell
361,706
-10,111
-3% -$1.72M 0.66% 38
2021
Q4
$63.6M Sell
371,817
-2,808
-0.7% -$460K 0.58% 40
2021
Q3
$60.5M Sell
374,625
-4,966
-1% -$847K 0.6% 40
2021
Q2
$62.5M Sell
379,591
-130
-0% -$21.5K 0.63% 41
2021
Q1
$62.4M Sell
379,721
-5,316
-1% -$860K 0.69% 40
2020
Q4
$60.6M Sell
385,037
-4,088
-1% -$603K 0.68% 40
2020
Q3
$57.9M Sell
389,125
-9,514
-2% -$1.41M 0.73% 37
2020
Q2
$56.1M Sell
398,639
-1,458
-0.4% -$212K 0.77% 35
2020
Q1
$52.5M Sell
400,097
-27,765
-6% -$3.94M 0.88% 33
2019
Q4
$62.4M Sell
427,862
-53,983
-11% -$7.32M 0.84% 33
2019
Q3
$62.3M Sell
481,845
-18,030
-4% -$2.38M 0.91% 33
2019
Q2
$69.6M Sell
499,875
-8,036
-2% -$1.11M 1.01% 31
2019
Q1
$71M Sell
507,911
-3,333
-0.7% -$446K 1.08% 31
2018
Q4
$66M Buy
511,244
+3,827
+0.8% +$534K 1.19% 28
2018
Q3
$70.1M Sell
507,417
-2,693
-0.5% -$358K 1.11% 31
2018
Q2
$61.9M Sell
510,110
-14,187
-3% -$1.77M 1.07% 31
2018
Q1
$67.2M Sell
524,297
-65,899
-11% -$8.91M 1.22% 27
2017
Q4
$82.5M Sell
590,196
-6,501
-1% -$906K 1.51% 23
2017
Q3
$77.6M Sell
596,697
-745
-0.1% -$98.8K 1.5% 24
2017
Q2
$79.3M Sell
597,442
-3,332
-0.6% -$425K 1.58% 23
2017
Q1
$74.8M Sell
600,774
-1,895
-0.3% -$226K 1.56% 24
2016
Q4
$69.4M Sell
602,669
-4,615
-0.8% -$533K 1.55% 23
2016
Q3
$71.7M Sell
607,284
-5,188
-0.8% -$629K 1.64% 25
2016
Q2
$74.3M Sell
612,472
-7,688
-1% -$874K 1.71% 24
2016
Q1
$67.1M Sell
620,160
-10,232
-2% -$1.06M 1.58% 24
2015
Q4
$64.8M Sell
630,392
-9,926
-2% -$998K 1.6% 25
2015
Q3
$62.4M Hold
640,318
1.59% 26
2015
Q2
$62.4M Sell
640,318
-5,500
-0.9% -$551K 1.59% 26
2015
Q1
$65M Sell
645,818
-11,545
-2% -$1.17M 1.64% 24
2014
Q4
$68.7M Buy
657,363
+1,947
+0.3% +$205K 1.76% 19
2014
Q3
$69.9M Sell
655,416
-2,870
-0.4% -$298K 1.89% 19
2014
Q2
$68.9M Sell
658,286
-7,905
-1% -$799K 1.86% 20
2014
Q1
$65.4M Sell
666,191
-2,074
-0.3% -$192K 1.79% 21
2013
Q4
$61.2M Sell
668,265
-4,614
-0.7% -$425K 1.69% 20
2013
Q3
$58.3M Sell
672,879
-8,619
-1% -$773K 1.78% 20
2013
Q2
$58.5M Buy
+681,498
New +$57.8M 1.83% 19

Other funds holding JNJ

Loring Wolcott & Coolidge Fiduciary Advisors's JNJ Position: Q2 2026 in Review

Loring Wolcott & Coolidge Fiduciary Advisors reduced its Johnson & Johnson (JNJ) stake by 1.4% in Q2 2026, selling an estimated $812K and leaving 252,775 shares worth $64.2M. The position accounts for 0.62% of the portfolio, ranked #40.

Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in JNJ in Q2 2013 and has held it in 53 quarters since. The position peaked at $82.5M in Q4 2017. 3,174 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Loring Wolcott & Coolidge Fiduciary Advisors held 252,775 shares of Johnson & Johnson worth $64.2M as of Q2 2026.
  • Loring Wolcott & Coolidge Fiduciary Advisors sold 3,486 Johnson & Johnson shares in Q2 2026, an estimated $812K.
  • Johnson & Johnson made up 0.62% of Loring Wolcott & Coolidge Fiduciary Advisors's portfolio in Q2 2026, its #40 holding.
  • Loring Wolcott & Coolidge Fiduciary Advisors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 53 quarters since.
  • Loring Wolcott & Coolidge Fiduciary Advisors's Johnson & Johnson position peaked at $82.5M in Q4 2017.
  • 3,174 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.